New kinase and HDAC hybrid inhibitors: recent advances and perspectives - Anonimysed Supplementary Material.docx

Table S1. Hybrid RTK/HDAC inhibitors (1-19) developed in the last years. Table S2. Hybrid non-receptor TK/HDAC inhibitors 20 28) developed in the last years. Table S3. Hybrid SK/HDAC inhibitors (29-39) developed in the last years. Table S4: Hybrid LK/HDAC inhibitors (40-46) developed in the last years.